Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Knowledge of the excess risk posed by specific cardiovascular syndromes could help in the development of strategies to reduce premature mortality among patients with chronic kidney disease (CKD). The rates of atherosclerotic vascular disease, congestive heart failure, renal replacement therapy, and death were compared in a 5% sample of the United States Medicare population in 1998 and 1999 (n = 1,091,201). Patients were divided into the following groups: 1, no diabetes, no CKD (79.7%); 2, diabetes, no CKD (16.5%); 3, CKD, no diabetes (2.2%); and 4, both CKD and diabetes (1.6%). During the 2 yr of follow-up, the rates (per 100 patient-years) in the four groups were as follows: atherosclerotic vascular disease, 14.1, 25.3, 35.7, and 49.1; congestive heart failure, 8.6, 18.5, 30.7, and 52.3; renal replacement therapy, 0.04, 0.2, 1.6, and 3.4; and death, 5.5, 8.1, 17.7, and 19.9, respectively (P < 0.0001). With use of Cox regression, the corresponding adjusted hazards ratios were as follows: atherosclerotic vascular disease, 1, 1.30, 1.16, and 1.41 (P < 0.0001); congestive heart failure, 1, 1.44, 1.28, and 1.79 (P < 0.0001); renal replacement therapy, 1, 2.52, 23.1, and 38.9 (P < 0.0001); and death, 1, 1.21, 1.38, and 1.56 (P < 0.0001). On a relative basis, patients with CKD were at a much greater risk for the least frequent study outcome, renal replacement therapy. On an absolute basis, however, the high death rates of patients with CKD may reflect accelerated rates of atherosclerotic vascular disease and congestive heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationLevey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
Manjunath, G., Tighiouart, H., Ibrahim, H., MacLeod, B., Salem, D. N., Griffith, J. L., Coresh, J., Levey, A. S., & Sarnak, M. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02663-3 · Cited by 920
Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States
Muntner, P., He, J., Hamm, L., Loria, C., & Whelton, P. K. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133745 · Cited by 829
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
Wright, R. S., Reeder, G. S., Herzog, C. A., Albright, R. C., Williams, B. A., Dvorak, D. L., Miller, W. L., Murphy, J. G., Kopecky, S. L., & Jaffe, A. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00007 · Cited by 595
Self-citationShlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00006 · Cited by 559
Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study
Henry, R. M. A., Kostense, P. J., Bos, G., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00571.x · Cited by 552
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried, L. F., Shlipak, M. G., Crump, C., Kronmal, R. A., Bleyer, A. J., Gottdiener, J. S., Kuller, L. H., & Newman, A. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00163-3 · Cited by 535
Cited by
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,104
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
The EVOLVE Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205624 · Cited by 971
Age Affects Outcomes in Chronic Kidney Disease
O'Hare, A. M., Choi, A. I., Bertenthal, D., Bacchetti, P., Garg, A. X., Kaufman, J. S., Walter, L. C., Mehta, K. M., Steinman, M. A., Allon, M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040422 · Cited by 747
Tyson, C. C., & Coffman, T. M. (2017) · Nephron · doi:10.1159/000455130 · Cited by 710
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
Yamagata, K., Ishida, K., Sairenchi, T., Takahashi, H., Ohba, S., Shiigai, T., Narita, M., & Koyama, A. (2007) · Kidney International · doi:10.1038/sj.ki.5002017 · Cited by 624
Chronic kidney disease management in the United Kingdom: NEOERICA project results
Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J., & Farmer, C. K. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002273 · Cited by 434
Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
Coca, S. G., Krumholz, H. M., Garg, A. X., & Parikh, C. R. (2006) · JAMA · doi:10.1001/jama.296.11.1377 · Cited by 408
Raj Krishnamurthy, V. M., Wei, G., Baird, B. C., Murtaugh, M., Chonchol, M. B., Raphael, K. L., Greene, T., & Beddhu, S. (2012) · Kidney International · doi:10.1038/ki.2011.355 · Cited by 409
Management of Hypertension in Chronic Kidney Disease
Pugh, D., Gallacher, P. J., & Dhaun, N. (2019) · Drugs · doi:10.1007/s40265-019-1064-1 · Cited by 401
Palmer, S. C., Mavridis, D., Navarese, E., Craig, J. C., Tonelli, M., Salanti, G., Wiebe, N., Ruospo, M., Wheeler, D. C., & Strippoli, G. F. M. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62459-4 · Cited by 395
Testing for chronic kidney disease: a position statement from the National Kidney Foundation
Vassalotti, J. A., Stevens, L. A., & Levey, A. S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.013 · Cited by 331
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Perkovic, V., Hegbrant, J., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007784.pub2 · Cited by 331
Physical Activity and Mortality in Chronic Kidney Disease (NHANES III)
Beddhu, S., Baird, B. C., Zitterkoph, J., Neilson, J., & Greene, T. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01970309 · Cited by 331
Weiner, D. E., Tabatabai, S., Tighiouart, H., Elsayed, E., Bansal, N., Griffith, J., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.021 · Cited by 325
Chronic Kidney Disease in the United States: A Public Policy Imperative
Rettig, R. A., Norris, K., & Nissenson, A. R. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02330508 · Cited by 307
Newsome, B. B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.609 · Cited by 302
Advanced Glycation End-Products (AGEs) and Heart Failure: Pathophysiology and Clinical Implications
Hartog, J. W. L., Voors, A. A., Bakker, S. J. L., Smit, A. J., & van Veldhuisen, D. J. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.009 · Cited by 299
Renal and cardiovascular morbidity after partial or radical nephrectomy
Miller, D. C., Schonlau, M., Litwin, M. S., Lai, J., & Saigal, C. S. (2008) · Cancer · doi:10.1002/cncr.23218 · Cited by 286
Tentori, F., Wang, M., Bieber, B. A., Karaboyas, A., Li, Y., Jacobson, S. H., Andreucci, V. E., Fukagawa, M., Frimat, L., Mendelssohn, D. C., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12941213 · Cited by 281
The next generation of therapeutics for chronic kidney disease
Breyer, M. D., & Susztak, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 272
Decreased Kidney Function Among Agricultural Workers in El Salvador
Peraza, S., Wesseling, C., Aragon, A., Leiva, R., García-Trabanino, R. A., Torres, C., Jakobsson, K., Elinder, C. G., & Hogstedt, C. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.039 · Cited by 265
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
Dalrymple, L. S., Katz, R., Kestenbaum, B., Shlipak, M. G., Sarnak, M. J., Stehman-Breen, C., Seliger, S., Siscovick, D., Newman, A. B., & Fried, L. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1511-x · Cited by 262
Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies
DeLoach, S. S., & Townsend, R. R. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03340807 · Cited by 258
The Endothelin System and Its Antagonism in Chronic Kidney Disease
Dhaun, N., Goddard, J., & Webb, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121256 · Cited by 256
. Prediction, progression and outcomes of chronic kidney disease in older adults.
Anderson, S., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kaysen, G. A., Kusek, J. W., Nayfield, S. G., Schmader, K., Tian, Y., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080860 · Cited by 218
Guía Clínica Española del Acceso Vascular para Hemodiálisis
Ibeas, J., Roca-Tey, R., Vallespín, J., Moreno, T., Moñux, G., Martí-Monrós, A., del Pozo, J. L., Gruss, E., Ramírez de Arellano, M., Fontseré, N., et al. (2017) · Nefrología · doi:10.1016/j.nefro.2017.11.004 · Cited by 214
Undiagnosed hypertension among young adults with regular primary care use
Johnson, H. M., Thorpe, C. T., Bartels, C. M., Schumacher, J. R., Palta, M., Pandhi, N., Sheehy, A. M., & Smith, M. A. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000008 · Cited by 134
Xue, J. L., Eggers, P. W., Agodoa, L. Y., Foley, R. N., & Collins, A. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050524 · Cited by 117
Self-citationFarkouh, M. E., Sidhu, M. S., Brooks, M. M., Vlachos, H., Boden, W. E., Frye, R. L., Hartigan, P., Siami, F. S., Bittner, V. A., Chaitman, B. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.044 · Cited by 58
Hyre, A. D., Fox, C. S., Astor, B. C., Cohen, A. J., & Muntner, P. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.09.017 · Cited by 55
Geriatric Nephrology: Responding to a Growing Challenge
Rosner, M., Abdel-Rahman, E., & Williams, M. E. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08731209 · Cited by 56
Sprick, J. D., Mammino, K., Jeong, J., DaCosta, D. R., Hu, Y., Morison, D. G., Nocera, J. R., & Park, J. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00808.2021 · Cited by 28
Kousios, A., Hadjivasilis, A., Kouis, P., & Panayiotou, A. (2020) · doi:10.21203/rs.3.rs-104160/v1 · Cited by 1
Metadata
- Authors
- Foley, R. N., Murray, A. M., Li, S., Herzog, C. A., McBean, A. M., Eggers, P. W., & Collins, A. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-02
- Volume
- 16
- Issue
- 2
- Pages
- 489-495
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2146278956
- Cited by
- 972
- References
- 23
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.